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Background: Spontaneous autoimmune peripheral neuropathy including Guillain-Barré Syndrome (GBS) represents
as one of the serious emergencies in neurology. Although pathological changes have been well documented,
molecular and cellular mechanisms of GBS are still under-explored, partially due to short of appropriate animal
models. The field lacks of spontaneous and translatable models for mechanistic investigations. As GBS is preceded
often by viral or bacterial infection, a condition can enhance co-stimulatory activity; we sought to investigate the
critical role of T cell co-stimulation in this autoimmune disease.
Results: Our previous study reported that transgene-derived constitutive expression of co-stimulator B7.2 on antigen
presenting cells of the nervous tissues drove spontaneous neurological disorders. Depletion of CD4+ T cells in L31 mice
accelerated the onset and increased the prevalence of the disease. In the current study, we further demonstrated that
L31/CD4-/- mice exhibited both motor and sensory deficits, including weakness and paresis of limbs, numbness to
mechanical stimuli and hypersensitivity to thermal stimulation. Pathological changes were characterized by massive
infiltration of macrophages and CD8+ T cells, demyelination and axonal damage in peripheral nerves, while changes in
spinal cords could be secondary to the PNS damage. In symptomatic L31/CD4-/- mice, the disruption of the blood
neural barriers was observed mainly in peripheral nerves. Interestingly, the infiltration of immune cells was initiated in
pre-symptomatic L31/CD4-/- mice, prior to the disease onset, in the DRG and spinal roots where the blood nerve barrier
is virtually absent.
Conclusions: L31/CD4-/- mice mimic most parts of clinical and pathological signatures of GBS in human; thus
providing an unconventional opportunity to experimentally explore the critical events that lead to spontaneous,
autoimmune demyelinating disease of the peripheral nervous system.
Keywords: Autoimmune response, Demyelination, T cell co-stimulation, CD8+ T cells, Animal modelBackground
Guillain-Barré Syndrome (GBS) is an acute immune-
mediated polyradiculoneuropathy comprising a broad
spectrum of clinical variants, including acute inflammatory
demyelinating polyradiculoneuropathy (AIDP), acute motor
axonal neuropathy (AMAN), acute motor and sensory
axonal neuropathy (AMSAN) and the Miller-Fisher Syn-
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stated.progressive diffuse weakness or paralysis of the four limbs,
sensory loss or pain and areflexia [1]. The sudden and
unexpected onset of paralysis is devastating for patients
and represents one of the serious emergencies in neurology.
The pathological substrate for GBS has been well estab-
lished with immune cell infiltration, demyelination with or
without axonal damage in the peripheral nervous system
(PNS), nevertheless molecular and cellular mechanisms
have not been fully understood. Although experimental
allergic neuritis (EAN) induced by immunization with
peripheral nerve proteins or adoptive transfer of sensitized
T cells [2,3] has provided valuable information, it has been
criticized for its artificial manipulation [4]. Only one
animal model with spontaneous autoimmune peripherald. This is an Open Access article distributed under the terms of the Creative
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(NOD) mice [5].
T cell costimulation has a central role in autoimmunity
[6]. Infection could promote autoimmunity via inducing
the co-stimulatory activity in antigen presenting cells
(APCs), which are required to induce the expansion of
antigen-reactive T cells, migration of T cells to the site of
inflammation and the production of inflammatory media-
tors [7,8]. Expression of co-stimulatory molecule B7 was
enhanced in the CNS of MS patients and in inflamed
nerves of GBS patients [9,10]. Targeting B7.2/CD28
signaling pathway has been fairly common in experimen-
tal studies of autoimmune diseases [11].
We have previously reported that constitutive expression
of B7.2 on APCs in the nervous system (L31 mice) led to
neurological dysfunction with spontaneous demyelination
and immune cell infiltration in the spinal cords and spinal
roots [12]. Both T cells and the expression of B7.2 on spinal
cord microglia were required for the development of the
disease [12]. A dramatic skewing toward CD8+ T cells in
the nervous system suggests a critical role of CD8+ T
cells in the pathogenesis [12], which has been further
supported by the fact that depletion of CD4+ T cells in L31
mice accelerated the onset and increased the prevalence of
the disease [13].
In the current study, we used L31 mice on a genetic
background where CD4+ T cells were depleted (CD4-/-)
to investigate whether constitutive expression of B7.2
could also drive spontaneous demyelination in the PNS
and to seek insights for GBS in human. We observed
that in addition to motor deficits as reported previously,
L31/CD4-/- mice also developed sensory disorders, includ-
ing numbness to mechanical stimuli and hypersensitivity
to thermal stimulation. Severe demyelination, massive
infiltration of macrophages, CD8+ T cells, and axonal
damage were found predominantly in the PNS, while
changes in the spinal cords could be secondary to the
PNS damage. The data revealed that L31/CD4-/- mice
mimic most parts of clinical and pathological aspects
of GBS, suggesting constitutive expression of B7.2 in




L31 mice with constitutive expression of co-stimulatory
B7.2/CD86 were generated with MHC I promoter and Igμ
enhancer [14]. L31/CD4-/- mice have been described pre-
viously [13] and were maintained by successive backcross
to C57BL/6 mice for more than 7 generations. C57BL/6
mice bred and housed in the same facility were used as
controls. All procedures were in accordance with the
guidelines of the Canadian Council on Animal Care, and ap-
proved by the animal care committee of McGill University.In total, 49 L31/CD4-/- and 18 C57BL/6 mice (controls),
aged at 2-6 months, were included in the study. 29 L31/
CD4-/- symptomatic mice and 6 C57BL/6 mice were
monitored for their clinical scores and behavioral responses.
20 L31/CD4-/- mice were euthanized before disease onset,
as pre-symptomatic mice for tissue collection.
Instruments and reagents
All instruments and reagents have been used in the study
were listed in Additional file 1: Table S1.
Assessment of neurological disorders
All mice included in the current study had their disease
onset between 2-4 months after birth. Animals whose
clinical score ≥4 were excluded from sensory tests.
Clinical scores for motor deficits: 0 = normal; 1 = reduced
tonus of tail and/or limp tail; 2 = weakness of one hind
limb, staying in clasping or outstretching position when
lifted by the tail; 3 = weakness of two hind limbs, both
staying in clasping or outstretching position when lifted
by the tail; 4 = paresis or splaying of one hind limb;
5 = paresis or splaying of two hind limbs; 6 = moribund
or death. L31/CD4-/- transgenic mice with clinical score
at 0 were defined as pre-symptomatic mice.
Rotarod assay was used to assess mouse motor
coordination. The task included a speed ramp from 0
to 30 rpm over 60 s, followed by an additional 240 s at
the maximal speed. The time that each animal walked
on the rod before falling was recorded. A decrease in
walking time is suggestive of motor impairment.
von Frey Test was performed to test paw sensitivity to
mechanical stimuli. Calibrated monofilaments were
applied to the plantar surface of the hindpaw and the
50% threshold to withdraw was calculated as previously
described [15]. A decrease in threshold suggests the
development of mechanical allodynia.
Acetone Test was used to evaluate sensitivity to cold
stimuli. Total duration of acetone evoked behaviors
(flinching, licking or biting) was measured for 1 minute
after one drop of acetone (~25 μl) was applied to the
plantar surface of the hindpaw. An increase of
withdrawal duration indicates the cold allodynia.
Hot plate (55°C) was used as an unpleasant sensory
heat stimulus to measure pain response. The latency
to paw-licking, squeaking, or distressful behavior
was measured. A decrease in latency suggests the
development of heat hypersensitivity.
Tissue preparation
For histological studies Lumbar spinal cords, L4-L6 DRGs,
dorsal roots and sciatic nerves were collected with trans-
cardiac perfusion of 4% paraformaldehyde or cold saline.
L4-L6 DRG, roots and sciatic nerves were cut either
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sections with a cryostat. Lumbar spinal cords were cut
into 25 μm-thick sections using microtome.
For flow cytometric studies Mice were deeply anaesthe-
tized with isoflurane. Approximately 1 cm long of lumbar
spinal cord and 2 cm long of sciatic nerves were collected.
Samples were diced into very small pieces in RPMI-1640
medium with streptomycine/penicilline and 10% fetal
bovine serum.
Immunohistochemistry and image acquisition
Regular immunofluorescent staining was performed as
previously described [16]. Tissues were incubated with
primary antibodies overnight at 4°C, followed by fluoro-
chrome-conjugated secondary antibodies for 60 min at
room temperature, and then counterstained with marker
for nucleus 4′, 6-Diamidino-2-phenylindole dihydrochlor-
ide (DAPI) and/or FluoroMyelin. Details of all antibodies
used in the study were listed in Table 1. Images were ac-
quired using an Olympus BX51 microscope equipped with
a color digital camera or Olympus confocal laser-scanning
microscope.
Flow cytometric analysis
Single-cell suspensions and blocking were prepared as
described previously [16]. Samples were then stained with
specific fluorochrome-conjugated antibodies for 25 min at
4°C. Staining specificity was identified by omitting anti-
bodies, and correlation of spectral overlap was done by
using negative and positive compensation beads. Cellular
events were acquired using a LSR Fortessa flow cytometer
and data was analyzed using Flow Jo software. Detail
information of antibodies used here was listed in Table 1.
Evaluation of blood-neural barrier permeability
Blood nerve barrier (BNB), blood spinal cord barrier
(BSCB) and blood brain barrier (BBB) permeability was
assessed using a micromolecular tracer sodium fluorescein
(NaFlu). The protocol was adopted and modified from
previous studies [17]. Briefly, NaFlu was administrated
intravenously (10%; 2 ml/kg) and allowed to circulate for
30 min. Then, mice were transcardially perfused with cold
saline for 10 min to remove intravascular NaFlu. The
choroid plexuse, meninge and epineurium were removed
before nervous tissues were dissected into different regions:
brain, cervical and lumbar spinal cords, and sciatic nerves.
Following tissue homogenization, the concentration of
NaFlu in supernatant was measured with spectropho-
tofluorometer. NaFlu was expressed as g/g of tissue.
Statistical analysis
Data is presented as means ± SEM. Unpaired t-test was
used to determine significance between groups. A value of
P < 0.05 was accepted as statistically significant.Results
Constitutive expression of B7.2 in APCs primed resident
macrophages in sciatic nerves and microglia in spinal cords
B7.2 expression was verified by flow cytometry on mac-
rophages and microglia, isolated from sciatic nerves and
lumbar spinal cords (Additional file 2: Figure S1). Increased
expression of B7.2 was detected in macrophages of L31/
CD4-/- mouse sciatic nerves (Figure 1A-B), which was
derived most likely from B7.2 transgene, as seen in
spinal microglia, resident macrophages in the CNS [13]. It
appears that B7.2 transgene primed macrophages by
increasing macrophage cell density (Figure 1A). Immu-
nohistochemistry analysis confirmed that L31/CD4-/-
mice had more Iba-1+ macrophages in sciatic nerves, and
these were elongated resident macrophages [18]. Many of
them were double-labelled by Iba-1 and B7.2 (Figure 1B).
Similar changes were detected in the spinal cords
(Figure 1C-D). Pre-symptomatic L31/CD4-/- mice had
more CD11b+ CD45+ microglia than wild type mice
(Figure 1C). Many of them expressed B7.2, while the
expression of B7.2 was almost undetectable in wild
type mice (Figure 1C-D).
L31/CD4-/- mice developed spontaneous motor and
sensory neurological disorders
Almost all L31/CD4-/- mice developed motor deficits
(Additional file 3: Video 1 and 2, Figure 2A) within 4
months after birth. Majority (55%) demonstrated hind
limb weakness (score 2-3), while walking was not altered
significantly. However, 14% mice had difficulties walking
properly. One or two hind limbs were found with paresis,
in a splaying position (score 4-5). Whatever the severity
of the illness, the symptoms appeared suddenly, reaching
a maximum within 3-7 days. Most animals, after the
appearance of neurological signs, remained stable. Among
29 L31/CD4-/- symptomatic mice monitored for behavior,
4 died of illness (14%). No apparent recovery was found
within the observation period (maximum 2 months follow-
ing disease onset).
Poor coordination was observed in both pre-symptomatic
(clinical score = 0, ≥ 2 months old) and symptomatic
L31/CD4-/- mice (clinical score ≥1). The latency of fall
in Rotarod test dropped from 98.60 ± 12.01 sec in wild
type mice to 45.50 ± 7.27 sec in pre-symptomatic mice.
Symptomatic mice could only stand on the running rod
for 12.5 ± 2.72 sec (Figure 2B).
L31/CD4-/- mice also developed sensory disorders. Symp-
tomatic animals exhibited numbness to von Frey hair as
paw withdrawal thresholds reached at 3.48 ± 0.15 g,
while wild type and pre-symptomatic mice responded at
0.78 ± 0.07 g and 0.83 ± 0.21 g, respectively (Figure 2C).
However, they were hypersensitive to cold and heat
stimulation. Duration of withdrawal in acetone test
was increased (Figure 2D) and the hot plate latency
Table 1 List of antibodies used in the study
Antibody/dye Specificity Immunogen/clone Dilution Source Catalog#




17 kDa EF hand protein
expressed on macrophages
and microglia
Synthetic peptide of C-terminus
Iba-1 N’-PTGPPAKKAISELP-C’
1:1000 Wako 019-19741
Rat anti mouse CD86 Mouse B7.2 LPS-activated CBA/Ca mouse
splenic B cells
1:600 Biolegend 105010
Rabbit anti protein gene
Product 9.5 (PGP9.5)
All mammalian species,
PGP9.5 expressed on neuronal
cell bodies and axons in
central and peripheral
neural system
Human PGP 9.5 Protein purified





Mouse, rat and human,
ATF3 expressed on
damaged neurons
A peptide mapping at the
C-terminus of human ATF-3
1:2000 Santa cruz SC188











amino acids with the C-terminus
of human GLUT-1 coupled to
KLH (C-ELFHPLGADSQV)
1:6000 Merck millipore 07-1401
Secondary antibodies
for IHC
Alexa fluor 594 goat
anti-rabbit IgG
IgG heavy chains and all





Alexa fluor 488 goat
anti-rabbit IgG
IgG heavy chains and all





Alexa fluor 594 rabbit
anti-rat IgG
IgG heavy chains and all





Alexa fluor 488 rabbit
anti-rat IgG
IgG heavy chains and all

















Mouse CD11b+ cells C57BL/10 splenic T cells and
concanavalin A-activated
C57BL/10 splenocytes
1:50 BD pharmingen 553310
Rat anti-mouse CD45 APC Mouse CD45+ cells Clone 30‐F11 1:50 eBioscience 17-0451-82
Rat anti-mouse CD8 alpha
PerCP-Cy5.5
Mouse CD8+ cells Clone 53-6.7 1:50 eBioscience 45-0081-82
Rat anti-mouse CD86 (B7.2) PE Mouse B7.2+ cells Clone GL1 1:50 eBioscience 12-0862-82
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estingly, thermal hypersensitivity appeared prior to motor
dysfunctions, since alteration in response to cold and
heat stimulation was observed in pre-symptomatic mice
(Figure 2D-E).Demyelination and axonal damage in peripheral nerves
of symptomatic L31/CD4-/- mice
Immunohistochemistry studies demonstrated that myelin
(Figure 3B, F, K) and axonal structures (Figure 3F, K) in
pre-symptomatic mice remained in healthy condition.
Figure 1 Transgene-derived B7.2 constitutive expression primed macrophages and microglia in the nervous tissues. The number of
CD11b+ CD45+ macrophages in the sciatic nerves and microglia in the spinal cord, and the expression of B7.2 among these targeted cells was
quantified using fluorescent-activated cell sorting (FACS) analysis. The histogram represents the FACS analysis obtained from 3 animals per group.
Percentage of either macrophages (A) or microglia (C) expressing B7.2 is increased in L31/CD4-/- mice, compared with wild type animals. The
absolute number of macrophages in the nerves and microglia in the spinal cord is also higher in L31/CD4-/- mice than that of wild type mice (A, C)
(*: p < 0.05, ***: p < 0.001). Representative examples of immunohistochemistry analysis of macrophages in the sciatic nerves and microglia in the spinal
cords were depicted in (B) and (D). Note that in L31 /CD4-/- mice, many Iba-1+ macrophages and microglia were colocalized with B7.2 which was
almost undetectable in wild type mice. Scale bars: B, 50 μm; D, 500 μm.
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in pre-symptomatic mice appeared as wide straight lines
in longitudinal sections (Figure 3B) and wrapped around
PGP9.5+ axons in longitudinal (Figure 3F) and cross
sections (Figure 3K). However, focal (Figure 3C) or
severe, diffused (Figure 3D) myelin loss was detected in
symptomatic L31 CD4-/- mice. Destruction of the myelin
in symptomatic mice was most frequently accompanied
by axonal damage where the number of PGP9.5+ axonal
fibers was significantly reduced (Figure 3G, H, L). Never-
theless, some naked PGP9.5+ axonal fibers were found
in the area where myelin disappeared or fragmented
(Figure 3G, H, M, N), indicating demyelination might
occur, at least in some area, prior to the axonal damage.
Image with high magnification in Figure 3I revealed a
cell-shaped myelin labeling with a DAPI+ nucleus inside,
suggesting presumably it could be a macrophage engulfing
myelin debris, while two nude axons were apposed closely.
The detection of ATF3, a marker for neuronal degener-
ation, in DRG sensory neurons (Figure 3O), as well as
in spinal cord motor neurons (Figure 3P) suggests that
both sensory and motor neurons were affected.
Massive immune cell infiltration in the sciatic nerves of
symptomatic L31/CD4-/- mice
In parallel to the demyelination and axonal damage, there
was a massive infiltration of immune cells into the nerves
(Figure 4). They consisted of mainly round-shaped Iba-1+
macrophages (Figure 4A) and CD8+ T cells (Figure 4B).Apart from a slight increase of elongated resident mac-
rophages (Figure 4A, insert in the middle panel), no
round-shaped macrophages or CD8+ T cells were found in
the sciatic nerves of pre-symptomatic mice (Figure 4A-B).
Immune cell infiltration was confirmed by quantitative flow
cytometry analysis (Figure 4C, Additional file 4: Figure S2).
In symptomatic mice (Figure 4D), infiltrates were either
grouped in small foci or distributed diffusely. In the vicin-
ity of cellular clusters, myelin sheaths were disintegrated
or replaced by oval-shaped vacuoles. Fragmented myelin
was found within Iba-1+macrophages (yellow signals within
Iba-1+ cells). There were less infiltrates in areas where
myelin remained in healthy-shape (Figure 4D-left). Ma-
jority of infiltrated Iba-1+ macrophages had high levels
of B7.2 expression (Figure 4D-middle) and CD8+ T
cells were in close apposition with Iba-1+ macrophages
(Figure 4D-right).
Limited demyelination and immune cell infiltration in the
spinal cords of L31/CD4-/- mice
Myelin structures in the spinal cords of pre-symptomatic
mice remained intact. Very little spotted demyelinating
lesions could be found only in severely diseased animals.
Even then, they were restricted to the dorsal columns and
the areas surrounding ascending spinothalamic tracts
(Figure 5A, D and E - pink zone). Clusters of infiltrated
CD8+ T cells were seen within demyelinated spots or dam-
aged motor neurons (Figure 5A). A few isolated CD8+ T
cells were also detected in pre-symptomatic mice where
Figure 2 L31/CD4-/- mice developed spontaneous motor and sensory neurological disorders. The incidence of motor deficits in L31/CD4-/-
mice evaluated with established clinical scores was presented in (A). Rotarod test was performed to examine coordination ability. Compared with
wild type mice, the latency of fall dropped in both pre-symptomatic and symptomatic L31 mice (B) (n = 6/group, **: p < 0.01, ***: p < 0.001),
indicative of motor impairment. Pain responses to mechanical, cold and heat stimuli were assessed in wild type, pre-symptomatic and symptomatic
L31/CD4-/- mice. Animals that had their clinical score ≥4 were excluded from sensory tests. Only symptomatic L31/CD4-/- mice demonstrated
numbness to von Frey hair stimulation (C) (n = 6/group, ***: p < 0.001). However, thermal hypersensitivity was observed in both pre-
symptomatic and symptomatic L31 mice, as the duration of withdrawal in acetone test increased (D) (n = 6/group, *: p < 0.05, ***: p < 0.001),
and the hotplate latency decreased (E) (n = 6/group, **: p < 0.01, ***: p < 0.001).
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Robust spinal microglia activation was detected in symp-
tomatic mice, predominantly in the grey matter (Figure 5B
and 5E-green zone). Iba-1+ microglia were clustered at the
dorsal horns where central afferents of sensory neurons
terminate and in the ventral horns surrounding motor
neurons (Figure 5B). The topography and morphological
changes are exactly the same as the spinal microglial
activation triggered by a physical injury to the sciatic
nerve [19], which suggests that microglial activation in
the grey matter of symptomatic mice could be a response
secondary to the PNS damage. However, in the white
matter, activated microglia were found restricted to the
zone where myelin was destroyed (Figure 5C, arrows).
The increase of CD11b+CD45+ microglia and CD8+ T
cells were quantified by flow cytometry (Figure 5D,
Additional file 5: Figure S3). Either in grey matter or white
matter, activated microglia had high levels of B7.2 expres-
sion as many B7.2+ cells were colocalized with ramified
Iba-1+ cells. Due to the incompatibility of the antibodies,CD8 and B7.2 antibodies could not be used on the
same tissue section, however presumably round shaped
B7.2 single labelled cells were infiltrated CD8+ T cells
(Figure 5E).
Disruption of blood nerve barrier in the sciatic nerves
of diseased L31/CD4-/- mice
The homeostasis of the nervous tissue is protected by
neural barriers, from periphery to central: BBB, BSCB
and BNB. As the integrity of the barriers is crucial for
immune cell recruitment, we examined the functional
status of the barriers with a fluorescent tracer, NaFlu.
Compared with intact sciatic nerves from wild type
mice, the content of NaFlu in diseased sciatic nerves
was dramatically increased (Figure 6A-B), suggesting a
disruption of the BNB. Interestingly, the levels of NaFlu
in the brain and the spinal cord of symptomatic mice
remained similar to those of wild type mice (Figure 6A),
further confirming the pathology was primarily in the
PNS.
Figure 3 Demyelination and axonal damage were found in the peripheral nerves of symptomatic L31/CD4-/- mice. Myelin in the sciatic
nerves was stained with FluoroMyelin. Representative illustrations from longitudinal (A-I) and cross (J-N) sections showed an intact myelin
structures in wild type (A, E, J) and pre-symptomatic L31 mouse sciatic nerves (B, F, K), and a focal (C, H) or diffused, severely damaged myelin
(D, G) in symptomatic L31 mice. In parallel with demyelination, the axonal damage evidenced by the loss of PGP9.5 staining was detected in
symptomatic L31 mice (G, H, L, M, N). Some naked PGP9.5+ axonal fibers were found in the area where myelin disappeared or fragmented
(G, H, L, M, N). I: Myelin labelling was found in a cell-shaped structure containing a DAPI+ nucleus, which suggests a macrophage with engulfed
myelin fragments. Two naked axonal fibers were located nearby. ATF3 positive signals were found in the cell bodies of both DRG sensory neurons
(O) and spinal cord ventral horn (VH) motor neurons (P). Scale bar: 50 μm.
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pre-symptomatic L31/CD4-/- mice, preceding disease
onset
If the BNB restricts the entrance of circulating immune
cells into the nerves, then vessels at 3 places of the PNS,
including spinal roots, DRG and nerve terminals, are
physiologically permeable to various components in the
circulation, where most immune cells could definitely have
direct access to the endoneurium. While there were some
resident Iba-1+ macrophages and no CD8+ T cells in the
DRG and the roots of wild type mice (Figure 7A), immune
infiltrates were apparent in these neural structures of
pre-symptomatic animals (Figure 7B), which was not
the case in sciatic nerves, nor in spinal cords. It was
possible to detect the slightest degree of infiltration,
presumably the earliest pathologic changes (Figure 7B,
upper panels) and also significant amount of both macro-
phages and CD8+ T cells with high levels of B7.2 expression
(Figure 7B, bottom panels) suggesting a status close to
disease onset. Not surprisingly, the DRG and roots ofsymptomatic mice were virtually flooded with both mac-
rophages and CD8+ T cells, where DRG sensory neurons
were barely observable (Figure 7C).
Discussion
We report here that mice that have been genetically modi-
fied to have an increased expression of co-stimulator B7.2
on APCs of the nervous system developed spontan-
eous autoimmune peripheral polyneuropathy. Pathological
changes were characterized by immune cell infiltration,
demyelination and axonal damage in peripheral nerves,
with restricted damage in spinal cords. The infiltration of
immune cells was initiated, prior to the disease onset, in
the DRG and the spinal roots where the BNB is physiolo-
gically fenestrated.
L31/CD4-/- mice mimic clinical and pathological aspects
of GBS in human
The most common initial symptoms of GBS are numbness,
paresthesia, weakness and pain in the limbs or some
Figure 4 Massive infiltration of immune cells in sciatic nerves of L31/CD4-/- mice. Cell infiltration in the diseased sciatic nerves was first
evidenced by the significant increase of DAPI labelled cell number (A-B). Immunohistochemistry analysis demonstrated that while there was a
slight increase of elongated (insert) Iba-1+ cells in the pre-symptomatic L31/CD4-/- mice, nerves from the symptomatic L31/CD4-/- mice were
submerged with round-shaped (insert) infiltrated Iba-1+ macrophages (A). While there were abundant CD8+ T cells found in the sciatic nerves of
symptomatic L31 mice, no CD8+ T cell infiltration was detected in pre-symptomatic L31/CD4-/- mice (B). Quantitative analysis with FACS (n = 3/
group) confirmed the immunohistochemistry observation (**: p < 0.01, ***: p < 0.001) (C). In symptomatic L31 mouse sciatic nerves, infiltrates
could either group in small foci (D-left) or be distributed diffusely (A/B-right). Fragmented myelin were found within Iba-1+macrophages (yellow
signals within Iba-1+ cells). There were less infiltrates in the area where myelin remained in healthy shape (D-left). Majority of infiltrated Iba-1+
macrophages had high levels of B7.2 expression (D-middle) and CD8+ T cells were in close apposition with Iba-1+ macrophages (D-right). Scale
bar: 200 μm.
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Figure 5 Limited demyelination and immune cell infiltration was detected in the spinal cords of L31/CD4-/- mice. Only isolated myelin
loss was found in the spinal white matter of symptomatic L31/CD4-/- mice together with few CD8+ T cell clusters (A). CD8+ T cells were also
found in the grey matter of some symptomatic L31/CD4-/- mice, gathered near motor neurons (A). Occasionally very few isolated CD8+ T cells
were found even in pre-symptomatic L31/CD4-/- mouse spinal cords (A). In symptomatic L31/CD4-/- mice, robust spinal microglia activation was
detected, mainly in the grey matter. Iba-1+ microglia were clustered at the dorsal and ventral horns (B). Morphological changes were revealed
with confocal microscope (B-left panels). In the white matter of diseased spinal cord, some demyelinated spots (C-arrows) were found in the
dorsal column where Iba-1+ microglia gathered (C). Quantitative analysis of CD11b+CD45+ microglia and CD8+ T cells using FACS (n = 3/group)
confirmed the immunohistochemistry observation (*: p < 0.05, **: p < 0.01) (D). Increased B7.2 expression was found in symptomatic spinal cords,
on ramified Iba-1/B7.2 double labelled microglia, or on round B7.2 single labelled cells, presumably CD8+ T cells (E). Scale bars: A, 100 μm; B, left,
500 μm, right, 10 μm; C, 100 μm; E, 50 μm.
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gressive bilateral and relatively symmetric weakness of
the limbs, and the weakness progresses over a period
of 12 hours to 28 days before a plateau is reached [20].
Our results demonstrated that L31/CD4-/- mice replicated
many clinical aspects of this complex human autoimmuneFigure 6 Blood nerve barrier in the sciatic nerves of diseased L31/CD
and BNB) was examined with a fluorescent dye NaFlu (MW, 376 Da) injecte
spinal cord and the sciatic nerve of wild type and the symptomatic L31/CD
nervous tissues was detected only in the nerve (n = 3/group, ***: p < 0.001
confirmed the dye extravasation in the symptomatic L31 mice. Glut1 was u
bar: 100 μm.disease, including both sensory and motor deficits, and a
temporal course of an acute onset and a stable progression
[21-23]. L31/CD4-/- mice also imitated pathological changes
in GBS, with characteristic lymphocytes and macrophages-
associated demyelination and axonal damage at the periph-
eral nerves, suggesting these mice might represent more4-/- mice was disrupted. The integrity of neural barriers (BBB, BSCB
d intravenously. Quantification of NaFlu content in the brain, the
4-/- mice revealed that a significant increase of the dye within the
) (A). Histological analysis on the cross sections of the sciatic nerves
sed to label blood vessels, perinurium and epineuriums (B). Scale
Figure 7 Focal inflammatory reaction appeared in the DRG and the roots of pre-symptomatic L31/CD4-/- mice, preceding the disease
onset. While there were only few resident macrophages and no CD8+ T cells in the DRG and the roots of wild type mice (A), both types of
immune cells were found in these two organs in pre-symptomatic L31/CD4-/- mice (B). Some mice showed a slightest degree of infiltration,
presumably the earliest pathologic changes (B-upper panels), some had significant amount of both Iba1+ macrophages and CD8+ T cells with
increased B7.2 expression (B-bottom panels) suggesting the status close to the disease onset (B). In symptomatic L31/CD4-/- mice, the DRG and
the roots were fulfilled with infiltrated Iba1+ macrophages and CD8+ T cells. Both expressed high levels of B7.2 (C). Scale bar: 100 μm.
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http://www.actaneurocomms.org/content/2/1/5closely axonal variants of GBS. Although it remains to
be determined what are the specific antigens (myelin or
axon or both) for autoimmune response, demyelination
in peripheral nerves of L31/CD4-/- mice is still distinguish-
able with myelin loss secondary to Wallerian degeneration
by the massive infiltration of T cells which was initiated
prior to the damage of the nervous tissues. Comparable to
what we observed restricted damage in spinal cords, loss
of myelinated fibers in posterior tracts or inflammatory in-
filtrates/spinal microglia activation in the grey matter have
been reported in human GBS [24,25]. Similar neurological
deficits and pathological changes in peripheral nerves
were also detected in L31 mice (data not shown). The
L31/CD4-/- mouse model had many similarities with the
EAN [3,26], one of the essential tools in the research of
autoimmune demyelinating diseases of the PNS. However
the use of EAN was restricted due to the administration of
powerful immune adjuvants to break-down self-tolerance.
The field lacks of spontaneous and translatable models for
mechanistic studies. The impressive resemblance between
the L31/CD4-/- mouse model and human GBS implies itas an unequivocal experimental setting for spontaneous
autoimmune peripheral polyneuropathy, especially as it
allows taking advantage of the wealth of genetic resources
on the C57BL/6 background.
L31/CD4-/- model provides genetic background for
deciphering molecular and cellular mechanisms in GBS
Co-stimulatory signals play a key role in regulating T cell
activation and are believed to have a decisive influence in
the induction and penetration of cellular effecter mecha-
nisms in spontaneous autoimmune peripheral polyneurop-
athy. Sensitization of APCs by increasing the expression of
B7.2 through genetic approaches simulates certain common
pre-dispositive conditions in GBS, e.g., infection, which is
usually the most potent stimulus for B7 expression [27,28].
T cells are required in the pathogenic sequence of immune-
mediated nerve damage [29], but the relative contributions
of CD4+ and CD8+ T cells are controversial. Although most
inflammatory infiltrates in the PNS of rats with EAN are
CD4+ cells [30], further studies indicated that CD8+ cells
may also be involved in the pathogenesis [31]. The necessity
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http://www.actaneurocomms.org/content/2/1/5of both CD4+ and CD8+ cells in the genesis of EAN was
confirmed by using CD4 and CD8 knock-out mice, where
the severity of clinical scores and histopathological manis-
festations of P0 peptide induced EAN was significantly
lower than those in their wild type counterparts [32]. In
human GBS, very limited post mortem and biopsy data
is available. However, one autopsy study provided clear
evidence for a potential involvement of cytotoxic T cells
in demyelination. Wanschitz et al [33] reported that in
all 11 examined subjects, among infiltrated endoneurial
T cells, the ratio of CD8+ to CD3+ was around 0.7 to 1.4.
The density of CD8/CD3 double positive T cells increased
significantly in cases with more than 4 weeks duration of
illness. Many of these CD8+ cells were found granzyme B
positive; Schwann cells and myelin sheaths were detected
with upregulation of MHC class I molecules [33]. In coinci-
dence with the observation in GBS patients, our previous
and current studies with L31 and L31/CD4-/- mice demon-
strated that 1) altering co-stimulation signals primed APCs
in the nervous tissue mice and drove a predominately
CD8+ T cell mediated autoimmune reaction [12], 2) CD8+
cells are able to lead to demyelination in the peripheral
nerves if they can find co-stimulation in the PNS; 3)
The demyelinating disease can be initiated in the absence
of CD4+ T cells, even displaying accelerated disease devel-
opment and increased expressivity [13], which indicates
an immunoregulatory role for CD4+ T cells in disease
pathogenesis. Hence, L31 and L31/CD4-/- mice are unique
to understand molecular pathways by which CD8+ T cells
are involved in demyelination and axonal damage. Albeit,
a characterization of functional phenotypes of CD8+ cells
in the demyelinating nerves at different stages of the dis-
ease is essential, which will provide insights to understand
the roles of CD8+ cells in the pathogenesis. Furthermore,
crucial questions with regard to the decisive contribution
of macrophages, as well as interaction between macro-
phages and lymphocytes in the context of demyelination
and axonal loss could be explored in L31 and L31/CD4-/-
mice. However, whether and to what extent antibody
mediated humoral immunity is involved in the disease
genesis of L31 and L31/CD4-/- mice need to be determined
in future experiments.
Limitation of L31 and L31/CD4-/- mice as a model for
human GBS
Most patients with GBS recover spontaneously, 62% had
made a complete or almost complete recovery at one year
[34]. However, neurological disorders in either L31 [12] or
L31/CD4-/- mice, with a sudden onset, seem to persist and
remain stable. Whether severe myelin/axonal damage and
absence of overt recovery in L31/CD4-/- and L31 mice
could be attributed to the lack of CD4+ T cell population
in the symptomatic nerves is an intriguing topic for
further investigation. Or it might be due to the fact thatthis model reflects more closely to axonal variants of GBS,
since most AMAN patients have more delayed recovery
than AIDP [35] and ASMAN has been associated with a
more severe course and poorer prognosis [36].
Proposed cascade of autoimmune demyelination in
L31/CD4-/- (and L31) model: implication for GBS
It remains presently elusive how the cascade of auto-
immune responses targeting PNS structures is ignited.
The fact that infiltration of immune cells was initiated
before disease onset, in the roots and the DRG where
the BNB is virtually absent [37] led us to propose the
following cascade: 1) Transgene or infection derived- over-
expression of co-stimulator B7.2 sensitizes APCs in the
nervous tissue; 2) T cells first access the nervous tissue
during immune surveillance through the DRGs and the
roots where the endoneurial vasculature is basically per-
meable to various components in the blood stream; 3) T
cells, especially CD8+ T cells that have specificities for PNS
self-antigens presented by primed macrophages are en-
gaged in productive antigen recognition and are reactivated
due to the high levels of B7.2; 4) In aid with massive infil-
tration of macrophages, CD8+ T cells exert their cytotoxic
effector functions, leading to destructive autoimmunity;
5) CD4+ T cells, could in fact, exert immunoregulatory
functions during the disease course.
Conclusion
In conclusion, with constitutive expression of B7.2 in APCs
of the nervous tissues, L31/CD4-/- (and L31) mice mimic
many clinical and pathological signatures of GBS in human
and provides an unconventional opportunity to experimen-
tally explore the critical events that lead to spontaneous,
autoimmune demyelinating disease of the PNS.
Additional files
Additional file 1: Table S1. List of instruments and reagents used in
the study.
Additional file 2: Figure S1. Representative experiment of B7.2
expression in the nervous tissues using flow cytometry analysis. Single-cell
suspension was prepared from sciatic nerves (A) and spinal cords (B) of wild
type and pre-symptomatic L31/CD4-/- mice. Number of macrophages
(CD11b+CD45+) in the nerves and microglia (CD11b+CD45+) in the spinal
cords was counted among 2 × 104 cells isolated from each tissue sample
(upper panels). Histograms for B7.2 expression were gated on
CD11b+CD45+ cells (lower panels). Note that compared with wild type mice,
B7.2 expression level in L31/CD4-/- transgenic mice is up-regulated in the
nerves (6.13% vs 1.33%) as well as in the spinal cords (44.30% vs 0%). The
number of macrophages and microglia also increased before the onset of
the disease, 3.40% vs 0.46% and 1.92% vs 1.13%, respectively.
Additional file 3: Video 1 and 2. L31/CD4-/- mice developed motor
deficits. When lifted by tail, B7.2 L31 Tg (L31/CD4-/-) mouse had difficulty
to struggle, it remained in clasping position, suggesting weakness of
both hind limbs (score 3) (video 1). B7.2 L31 Tg (L31/CD4-/-) mouse
showed a limp tail with reduced tonus (score 1), while wild type mouse
can easily elevate the tail (video 2). B7.2 L31 Tg (L31/CD4-/-) mouse had
difficulty to walk properly and failed to support body weight when
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splaying position, indicating paresis of right hind limb (score 4) (Video 2).
Additional file 4: Figure S2. Representative experiment of
macrophages and CD8+ T cell infiltration in the sciatic nerves with flow
cytometry analysis 2 × 104 cells isolated from the sciatic nerves of either
wild type, or L31/CD4-/- pre-symptomatic or symptomatic mice were
stained with anti-CD45, anti-CD11b, anti-CD8α antibodies. Histograms for
macrophages (CD11b+) were gated on CD45+ cells (upper panels).
Histograms for CD8+ T cells were gated on CD45+ cells (lower panels).
A dramatic increase of CD11b+CD45+ macrophages and CD8+CD45+
T cells were found in symptomatic L31/CD4-/- mice, while increase of
immune cells in pre-symptomatic L31/CD4-/- mouse sciatic nerves was
almost undetectable or moderate.
Additional file 5: Figure S3. Representative experiment of microglia
and CD8+ T cell infiltration in the lumbar spinal cords with flow
cytometry analysis 2 × 104 cells isolated from the lumbar spinal cords of
either wild type, or L31/CD4-/- pre-symptomatic or symptomatic mice were
stained with anti-CD45, anti-CD11b, anti-CD8α antibodies. Histograms for
microglia (CD11b+) were gated on CD45+ cells (upper panels). Histograms
for CD8+ T cells were gated on CD45+ cells (lower panels). A significant
increase of CD11b+CD45+ microglia and CD8+CD45+ T cells were detected
in symptomatic L31/CD4-/- mouse spinal cords, with a slight change in
pre-symptomatic mice.
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